Sponsor hub
University of Washington clinical trial failures
Review 82 stopped clinical trials from University of Washington, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 6 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 58
- OTHER/UNKNOWN
- 18
- EFFICACY/FUTILITY
- 3
- SAFETY
- 3
Notable sponsors
- University of Washington
- 82
Related phases
- Phase II
- 44
- Phase I
- 20
- Unknown
- 8
- Phase IV
- 7
- Phase III
- 3
Crawlable stopped-trial records
Open ExploreShowing up to 82 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Phase II Recurrent B-Cell Non-Hodgkin Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
The trial closed early due to slow accrual.
Phase IV Anatomic Stage I Breast Cancer AJCC v8 trial by University of Washington. Stop reason: OPERATIONAL.
Study ended earlier than anticipated due to end of funding.
Phase II Muscle Invasive Bladder Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Study closed to accrual before meeting accrual goal due to major enrollment challenges based on the very rare disease indication studied and rapid changes in the therapy landscape.
Phase I Oral Cavity Squamous Cell Carcinoma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Terminated due to suboptimal delineation of fluorescence between tumor and native oral cavity mucosa.
Phase I Advanced Clear Cell Renal Cell Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Insufficient funding
Phase II Follicular Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
Closed per SRC Low Accrual Policy.
Unknown Hepatocellular Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual in Cohort B. (Accrual goal for Cohort A was met.)
Phase II Biochemically Recurrent Prostate Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Slow accrual
Phase I Recurrent Multiple Myeloma trial by University of Washington. Stop reason: OPERATIONAL.
Study terminated due to end of funding.
Phase II Recurrent Diffuse Large B-Cell Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
Study terminated to end of funding.
Phase I Sarcoma of the Extremity trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to end of funding
Unknown Chronic Pain trial by University of Washington. Stop reason: OPERATIONAL.
Contract was never finalized and UW GCA closed the study due to lack of funding and activity.
Phase II ATM Gene Mutation trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to insufficient funding
Phase I Advanced Soft Tissue Sarcoma trial by University of Washington. Stop reason: OPERATIONAL.
Study was terminated at completion of the Phase 1 dose escalation due to loss of financial support.
Phase II Castration-Resistant Prostate Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Withdrawal of funding
Phase II Urothelial Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Closed per SRC Low Accrual Policy
Phase I Mycoplasma Genitalium Infection trial by University of Washington. Stop reason: OPERATIONAL.
At Sponsor Request
Phase I Extensive Stage Lung Small Cell Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Closed per SRC Low Accrual Policy
Phase I Myeloid Neoplasm trial by University of Washington. Stop reason: SAFETY.
Terminated due to unfavorable risk-benefit ratio of investigational regimen.
Phase IV Platelet Function trial by University of Washington. Stop reason: OPERATIONAL.
Funding ended before the study could be completed,
Phase I Malignant Neoplasm in the Head and Neck trial by University of Washington. Stop reason: OPERATIONAL.
Study closed due to no accruals and change in the standard of care for this population
Phase II Castration-Sensitive Prostate Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual.
Phase II Extensive Stage Lung Small Cell Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Closed per SRC Low Accrual Policy. Study closed prior to any participants enrolled.
Phase II Castration-Resistant Prostate Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase II Dermatomyositis trial by University of Washington. Stop reason: OPERATIONAL.
Difficulty recruiting subjects
Phase II Metastatic Lung Non-Small Cell Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Withdrawn prior to opening to accrual.
Phase I Grade 3b Follicular Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual
Phase II Locally Advanced Lung Non-Small Cell Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase I Metastatic Head and Neck Squamous Cell Carcinoma trial by University of Washington. Stop reason: EFFICACY/FUTILITY.
Terminated by the sponsor due to lack of efficacy in study treatment.
Phase II Hodgkin's Lymphoma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Company providing drug terminated their oncology program
Phase II Advanced Hepatocellular Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase IV Genital Herpes trial by University of Washington. Stop reason: OPERATIONAL.
Investigator relocated and study funding ended.
Phase IV Alcohol Drinking trial by University of Washington. Stop reason: OPERATIONAL.
COVID-19 and expiration of funding
Phase IV Open tíbia Fracture With Sub-segmental Bone Loss trial by University of Washington. Stop reason: OPERATIONAL.
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention. Low enrollment and PI leaving institution
Phase II Prostate Adenocarcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase II Immune-Mediated Necrotizing Myopathy trial by University of Washington. Stop reason: OPERATIONAL.
No Participants Enrolled
Phase II COVID-19 trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Low number of events contributing to primary outcome
Phase II Metastatic Kidney Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase II Recurrent Plasma Cell Myeloma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to loss of funding and former PI left the institution
Phase II Lymphoid Leukemia trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual
Phase II Stage III Fallopian Tube Cancer trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to lack of funding
Phase I Castration-Resistant Prostate Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to insufficient funding
Phase II Ann Arbor Stage I Mantle Cell Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
Accrual goal not met
Unknown Estrogen Receptor Positive trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual
Phase I Posttraumatic Stress Disorder trial by University of Washington. Stop reason: OPERATIONAL.
Inadequate recruitment
Unknown HIV-2 Infection trial by University of Washington. Stop reason: OPERATIONAL.
COVID-19 and Funding
Phase II Prostate Adenocarcinoma Without Neuroendocrine Differentiation trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase II B Acute Lymphoblastic Leukemia trial by University of Washington. Stop reason: EFFICACY/FUTILITY.
Terminated due to lack of efficacy
Phase II Pharyngeal Gonococcal Infection trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Efficacy
Phase II Recurrent Melanoma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Change in standard of care
Phase II Marginal Zone Lymphoma trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to low accrual.
Phase II Gonadotropin Deficiency trial by University of Washington. Stop reason: OPERATIONAL.
No funding was obtained for this study.
Phase I Anaplastic Large Cell Lymphoma, ALK-Positive trial by University of Washington. Stop reason: OPERATIONAL.
Administrative closure
Phase II Cryptosporidiosis trial by University of Washington. Stop reason: OPERATIONAL.
Insufficient accrual rate
Phase II Estrogen Receptor Negative trial by University of Washington. Stop reason: OPERATIONAL.
No participants enrolled.
Phase I ALK Gene Translocation trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Immunotherapy approved for NSCLC in the first line setting
Phase II Adenocarcinoma of the Prostate trial by University of Washington. Stop reason: OPERATIONAL.
Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.
Phase II B Acute Lymphoblastic Leukemia trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Drugs unavailable
Phase III Chronic Post Traumatic Headache trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Study discontinued due to difficulty in enrolling eligible subjects
Phase II Cutaneous T-cell Lymphoma Stage I trial by University of Washington. Stop reason: OPERATIONAL.
Terminated due to slow accrual
Phase III HIV Infections trial by University of Washington. Stop reason: SAFETY.
There is no longer equipoise. DSMB recommended termination.
Unknown HIV Infections trial by University of Washington. Stop reason: SAFETY.
DSMB recommended termination because TI was safe but not durable.
Phase II Castration Levels of Testosterone trial by University of Washington. Stop reason: OPERATIONAL.
Withdrawn prior to opening to enrollment
Phase II Recurrent Colon Carcinoma trial by University of Washington. Stop reason: OPERATIONAL.
Funding ended
Phase II Vasospasm trial by University of Washington. Stop reason: OPERATIONAL.
Poor Enrollment
Phase I Refractory Multiple Myeloma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
One of the study drugs is not available.
Phase IV Shoulder Pain trial by University of Washington. Stop reason: OPERATIONAL.
Unable to continue enrollment due to lack of resources (research coordinator no longer available).
Phase I Breast Cancer trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Sponsor withdrew the study
Phase II Estrogen Receptor-positive Breast Cancer trial by University of Washington. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Laryngo-pharyngeal Reflux trial by University of Washington. Stop reason: OTHER/UNKNOWN.
The sponsor did not fund the study.
Phase I Stage IIIA Non-small Cell Lung Cancer trial by University of Washington. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Adult Primary Hepatocellular Carcinoma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Nausea and Vomiting trial by University of Washington. Stop reason: EFFICACY/FUTILITY.
Study stopped due to lack of efficacy in first 6 patients
Phase II Respiratory Distress Syndrome, Adult trial by University of Washington. Stop reason: OPERATIONAL.
Unable to meet enrollment number to complete study, study stopped June 30, 2007
Phase II Adult Acute Myeloid Leukemia in Remission trial by University of Washington. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase IV Giant Lymph Node Hyperplasia trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Research never begun.
Phase II HER2-positive Breast Cancer trial by University of Washington. Stop reason: OPERATIONAL.
Study ended early due to slow enrollment
Phase I Adult Anaplastic Astrocytoma trial by University of Washington. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Unknown Upper Respiratory Infections trial by University of Washington. Stop reason: OTHER/UNKNOWN.
Decided to conduct study in adults first
Phase I Recurrent Non-small Cell Lung Cancer trial by University of Washington. Stop reason: OPERATIONAL.
Low accrual
Unknown Appetite Regulation trial by University of Washington. Stop reason: OPERATIONAL.
This study is delayed. It was not funded.
Phase III Dental Caries trial by University of Washington. Stop reason: OPERATIONAL.
Unable to recruit sufficient number of subjects